Transcutaneous auricular vagus nerve stimulation (ta-VNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial
Yang H, Shi W, Fan J, Wang X, Song Y, Lian Y, Shan W, Wang Q
Neurotherapeutics · 2023
Key finding
At 20 weeks, the responder rate and relative seizure frequency reduction were significantly higher in the active taVNS group compared to controls, supporting non-invasive VNS for drug-resistant epilepsy.
- Condition
- Epilepsy
- Stimulation
- taVNS
- Evidence tier
- Randomised Controlled Trial
- Participants
- 150
Cite this study
Yang, H., Shi, W., Fan, J., Wang, X., Song, Y., Lian, Y., Shan, W., & Wang, Q. (2023). Transcutaneous auricular vagus nerve stimulation (ta-VNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial. Neurotherapeutics, 20(3), 870-880. https://doi.org/10.1007/s13311-023-01353-9
Related studies in Epilepsy
Can transcutaneous auricular vagus nerve stimulation be considered a viable adjuntive therapy in drug-resistant epilepsy? A systematic review and meta-analysis of randomized controlled trials
Moro et al. · Epilepsy & behavior : E&B · 2025 · Systematic Review / Meta-Analysis
The effect of Vagus nerve stimulation (VNS) on seizure control, cognitive function, and quality of life in individuals with drug-resistant epilepsy: A systematic review article
Melese et al. · Epilepsia open · 2024 · Systematic Review / Meta-Analysis
Effects of vagus nerve stimulation on cognitive function in patients with epilepsy: a systematic review and meta-analysis
Kong et al. · Frontiers in neurology · 2024 · Systematic Review / Meta-Analysis
Transcutaneous auricular vagus nerve stimulation for epilepsy
Zhang et al. · Seizure · 2024 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.